MBody AI MBAI
NASDAQ MBAI
$3.16 -0.38 (-10.73%)
As of: Oct 1, 2026 · 3:58 PM EDT

MBody AI (MBAI) EBITDA Margin (2022 - 2023)

Updated

MBody AI (MBAI) recorded EBITDA Margin of -95.96% in the year ended Dec 31, 2025, up 19305.38 percentage points from -19401.34% a year earlier.

Analysis

MBody AI (MBAI) EBITDA Margin (2022 - 2023) Analysis & Trends

Starting with the year ended Dec 31, 2021, MBody AI's EBITDA Margin history includes 4 years.

  • Annual EBITDA Margin has a four-year change of -140.21 percentage points (years ended Dec 2021 to Dec 2025).
  • The figure for the year ended Dec 31, 2025 is the highest annual EBITDA Margin since the year ended Dec 31, 2022.
  • Per Business Quant data, MBAI's EBITDA Margin was -19401.34% in the year ended Dec 31, 2024, 44.46% in the year ended Dec 31, 2022 (+0.21 pp) and 44.25% in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 21.86%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 41.08%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 25.55%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 31.93%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 24.62%
10 MBody AI 3.55 Mn 3.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -22.99%
Jun 30, 2022 -59.21%
API Access

MBody AI EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MBAI&period=max&api_key=YOUR_API_KEY